OGC
ONCS

One68 Global Capital’s OncoSec Medical Incorporated ONCS Stock Holding History

One68 Global Capital’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$144K Buy
+1,012
New +$108K 0.29% 74

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return

One68 Global Capital's ONCS Position: Q4 2020 in Review

One68 Global Capital opened a new position in OncoSec Medical Incorporated (ONCS) in Q4 2020: 1,012 shares worth $144K. The stake represents 0.29% of the portfolio and ranks #74 among its holdings.

31 funds tracked by Wall St. Rank hold ONCS as of Q4 2020.

  • One68 Global Capital held 1,012 shares of OncoSec Medical Incorporated worth $144K as of Q4 2020.
  • OncoSec Medical Incorporated was a new One68 Global Capital position in Q4 2020.
  • OncoSec Medical Incorporated made up 0.29% of One68 Global Capital's portfolio in Q4 2020, its #74 holding.
  • 31 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2020.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.